NCT05438953View on ClinicalTrials.gov

Follow-up of People at Risk of Monkeypox Infection: a Prospective Cohort Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

July 12, 2022

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
Monkey PoxMonkey Diseases
Interventions
BIOLOGICAL

Vaccination with MVA vaccine ( IMVANEX® and JYNNEOS®)

Participant of these arm will receive 2 doses of MVA vaccine spaced 28 days apart

Trial Locations (1)

Unknown

CIC Cochin-Pasteur, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER